Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children

The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-centre, double-blind (observer- and participan...

Full description

Saved in:
Bibliographic Details
Main Authors: Lusingu, John, Olotu, Ally, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Olivier, Aurélie, Benns, Sarah, Olomi, Raimos, Msham, Salum, Lang, Trudie, Gould, Jayne, Hallez, Karin, Guerra, Yolanda, Njuguna, Patricia, Awuondo, Ken O., Malabeja, Anangisye, Abdul, Omar, Gesase, Samwel, Dekker, Denise, Malle, Lincoln, Ismael, Sadiki, Mturi, Neema, Drakeley, Chris J., Savarese, Barbara, Villafana, Tonya, Ballou, W. Ripley, Cohen, Joe, Riley, Eleanor M., Lemnge, Martha M., Marsh, Kevin, Bejon, Philip, von Seidlein, Lorenz
Format: Artigo
Language:Inglês
Published: Public Library of Science 2010
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993932/
https://ncbi.nlm.nih.gov/pubmed/21124768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0014090
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items